Business, Policy & Funding
Breaking news on Genetics & Genomics business, policy & funding.
FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests
The agency said the issue could be related to current mixing parameters of the PCR reaction mixture resulting in overflow in wells of the reagent tray.
Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022
The guidance for next year assumes, among other things, $6.0 billion in revenue from clinical research services provider PPD, which Thermo Fisher is set to acquire this year.
In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More
News items for the week of Sept. 13, 2021.
Sep 16, 2021
Hong Kong-Based Prenetics to go Public via SPAC
Sep 16, 2021